BioSpace News Archive

FDA

Aerie Pharma’s 2nd Glaucoma Drug Gets FDA Approval

The U.S. Food and Drug Administration (FDA) approved Aerie Pharmaceuticals Rocklatan (netarsudil and latanoprost ophthalmic solution) to decrease elevated intraocular pressure (IOP) in open-angle glaucoma or ocular hypertension.

March 13, 2019
·
2 min read
·
Mark Terry
Drug Development

Celgene’s Abraxane Fails to Hit the Mark in a Phase III Pancreatic Cancer Study

While the primary endpoint of disease-free survival was not met, Celgene said overall survival, which was a secondary endpoint, was improved by the combination treatment.

March 13, 2019
·
2 min read
·
Alex Keown
BioCapital

BioSpace’s Global Biopharma Roundup: March 14

In addition to the planned BioNTech IPO, many other pharma and biotech companies in Europe, Asia and elsewhere shared news for the week.

March 13, 2019
·
4 min read
·
Alex Keown
BioMidwest

Esperion Announces Publication of Bempedoic Acid Study 1 Results in The New England Journal of Medicine

Over 52-Weeks, Bempedoic Acid was Observed to be Safe, Well-Tolerated, and Did Not Lead to Higher Overall Adverse Events Compared With Placebo

March 13, 2019
·
9 min read
Business

BioForest Hotbed: The Fastest-Growing Life Science Market

A recent report by the U.S. Bureau of Labor Statistics and CBRE Research identified Seattle—which happens to be the BioSpace Bio Forest Hotbed—as the fastest-growing life science market in the top 10 from 2014 to 2017, with a greater than 17-percent growth.

March 13, 2019
·
5 min read
·
Mark Terry
Deals

Koligo Therapeutics to bring 3D bio-printing to the ASX

Koligo Therapeutics a regenerative medicine and 3D bio-printing company to list on the ASX under the stock ticker “KOL”.

March 13, 2019
·
5 min read
Deals

Germany’s BioNTech Taps Banks to Prepare for $800 Million IPO

For BioNTech, the IPO will follow a funding round that brought about $270 million into the coffers of the privately-held company.

March 13, 2019
·
2 min read
·
Alex Keown
Drug Development

FDA Broadens Cancer Trial Eligibility With 5 New Guidance Documents

The FDA, as part of efforts to update clinical trial eligibility criteria, published four draft guidance documents on cancer clinical trial criteria and one final draft on adolescents in adult oncology trials.

March 13, 2019
·
3 min read
·
Mark Terry
Business

Minafin launches Minagro, new business unit targeting green and safer ingredients for agribusiness industry

The Minafin Group announces the launch of Minagro, a new global business unit dedicated to developing and marketing greener and safer ingredients for the crop care industry.

March 13, 2019
·
4 min read
Business

Oxford Biomedica Teams With Microsoft to Use AI to Improve Gene Therapies

The goal is to improve the yield and quality of next-generation gene therapy vectors—typically viruses—using artificial intelligence (AI) and machine learning.

March 13, 2019
·
3 min read
·
Mark Terry